Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes
- PMID: 36658631
- PMCID: PMC9850788
- DOI: 10.1186/s13027-023-00480-4
Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes
Erratum in
-
Correction: Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes.Infect Agent Cancer. 2023 Feb 2;18(1):6. doi: 10.1186/s13027-023-00484-0. Infect Agent Cancer. 2023. PMID: 36732833 Free PMC article. No abstract available.
Abstract
The role of gut microbiota and its products in human health and disease is profoundly investigated. The communication between gut microbiota and the host involves a complicated network of signaling pathways via biologically active molecules generated by intestinal microbiota. Some of these molecules could be assembled within nanoparticles known as outer membrane vesicles (OMVs). Recent studies propose that OMVs play a critical role in shaping immune responses, including homeostasis and acute inflammatory responses. Moreover, these OMVs have an immense capacity to be applied in medical research, such as OMV-based vaccines and drug delivery. This review presents a comprehensive overview of emerging knowledge about biogenesis, the role, and application of these bacterial-derived OMVs, including OMV-based vaccines, OMV adjuvants characteristics, OMV vehicles (in conjugated vaccines), cancer immunotherapy, and drug carriers and delivery systems. Moreover, we also highlight the significance of the potential role of these OMVs in diagnosis and therapy.
Keywords: Adjuvant; Biomarker; Drug delivery; Microbiota; Outer membrane vesicle; Vaccine.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
Figures


Similar articles
-
Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8+ T cells.Acta Biomater. 2019 Jun;91:248-257. doi: 10.1016/j.actbio.2019.04.033. Epub 2019 Apr 17. Acta Biomater. 2019. PMID: 31003032
-
High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.Microb Cell Fact. 2018 Oct 3;17(1):157. doi: 10.1186/s12934-018-1007-7. Microb Cell Fact. 2018. PMID: 30285743 Free PMC article.
-
Increased Production of Outer Membrane Vesicles by Salmonella Interferes with Complement-Mediated Innate Immune Attack.mBio. 2021 Jun 29;12(3):e0086921. doi: 10.1128/mBio.00869-21. Epub 2021 Jun 1. mBio. 2021. PMID: 34061589 Free PMC article.
-
Designer outer membrane vesicles as immunomodulatory systems - Reprogramming bacteria for vaccine delivery.Adv Drug Deliv Rev. 2017 May 15;114:132-142. doi: 10.1016/j.addr.2017.05.003. Epub 2017 May 10. Adv Drug Deliv Rev. 2017. PMID: 28501509 Review.
-
Bacterial Outer Membrane Vesicles: Role in Pathogenesis and Host-Cell Interactions.Antibiotics (Basel). 2023 Dec 28;13(1):32. doi: 10.3390/antibiotics13010032. Antibiotics (Basel). 2023. PMID: 38247591 Free PMC article. Review.
Cited by
-
Muropeptides and muropeptide transporters impact on host immune response.Gut Microbes. 2024 Jan-Dec;16(1):2418412. doi: 10.1080/19490976.2024.2418412. Epub 2024 Oct 22. Gut Microbes. 2024. PMID: 39439228 Free PMC article. Review.
-
Harnessing Bacterial Extracellular Vesicle Immune Effects for Cancer Therapy.Pathog Immun. 2024 Apr 23;9(1):56-90. doi: 10.20411/pai.v9i1.657. eCollection 2024. Pathog Immun. 2024. PMID: 38690563 Free PMC article. Review.
-
Study of the Molecular Mechanisms of the Therapeutic Properties of Extracellular Vesicles.Int J Mol Sci. 2023 Apr 12;24(8):7093. doi: 10.3390/ijms24087093. Int J Mol Sci. 2023. PMID: 37108256 Free PMC article.
-
Multivariate Analysis of Individual Bacterial Outer Membrane Vesicles Using Fluorescence Microscopy.Chem Biomed Imaging. 2024 Apr 19;2(5):352-361. doi: 10.1021/cbmi.4c00014. eCollection 2024 May 27. Chem Biomed Imaging. 2024. PMID: 38817321 Free PMC article.
-
Gram-negative bacterial sRNAs encapsulated in OMVs: an emerging class of therapeutic targets in diseases.Front Cell Infect Microbiol. 2024 Jan 30;13:1305510. doi: 10.3389/fcimb.2023.1305510. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38983695 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources